Ligand validation:3TT1

SOG: octyl 1-thio-beta-D-glucopyranoside

SOG is a Ligand Of Interest in 3TT1 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3TT1_SOG_A_520	24%	0%	0.252	0.885	6.12	7.7	6	15	9	0	100%	1
3TT1_SOG_A_521	19%	81%	0.223	0.923	0.26	0.56	-	-	1	0	40%	0.4
3TT1_SOG_B_521	15%	82%	0.238	0.905	0.26	0.53	-	-	3	0	40%	0.4
3TT1_SOG_B_520	12%	0%	0.326	0.858	4.15	9.26	6	10	14	0	100%	1
3TT1_SOG_A_522	2%	83%	0.29	0.646	0.27	0.5	-	-	0	0	40%	0.4
3TT3_SOG_A_520	0%	77%	0.949	0.629	0.25	0.67	-	-	0	0	40%	0.4
6TOS_SOG_B_406	70%	81%	0.109	0.927	0.31	0.51	-	-	0	0	100%	1
2VT4_SOG_A_403	67%	60%	0.141	0.95	0.59	0.92	-	-	0	0	100%	1
6YU6_SOG_A_507	64%	91%	0.138	0.937	0.18	0.39	-	-	3	0	100%	1
6TOT_SOG_A_405	55%	44%	0.159	0.929	0.91	1.24	1	1	0	0	100%	1
5G53_SOG_A_501	54%	39%	0.17	0.937	1.01	1.37	1	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.